Schonfeld Strategic Advisors LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2022$73,000
+102.8%
42,441
+196.5%
0.00%
Q4 2020$36,000
-77.9%
14,313
-77.9%
0.00%
-100.0%
Q3 2020$163,000
-73.5%
64,621
-65.7%
0.00%
-62.5%
Q2 2020$616,000
+962.1%
188,188
+1620.0%
0.01%0.0%
Q4 2016$58,00010,9410.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders